Skip to main content
Download PDF

Correction to: Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation

Trials volume 20, Article number: 322 (2019) Cite this article

The Original Article was published on 22 March 2019

Correction to: Trials

https://doi.org/10.1186/s13063-019-3272-0

After publication of the original article [1], the authors have notified us of an error in language used in the text:

  • The first sentence of the 6th paragraph under the Methods sections should read “Training was completed for each individual patient.”

  • The first sentence of the 3rd paragraph under Training of patients and site staff should read: “The site staff underwent face-to-face training and hands-on experience with the devices at investigator meetings or online training modules and took 2 hours to complete on average.”

The phrase “took 2 hours to complete on average” was moved from the first sentence to the second one.

Reference

  1. Bingham CO, et al. Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation. Trials. 2019;20:182. https://doi.org/10.1186/s13063-019-3272-0.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisions of Rheumatology and Allergy and Clinical Immunology, Johns, Hopkins University, 5200 Eastern Avenue, MFL Center Tower Room 404, Baltimore, MD, 21224, USA

    Clifton O. Bingham III

  2. Eli Lilly and Company, Indianapolis, USA

    Carol L. Gaich, Amy M. DeLozier, Kathryn D. Engstrom, April N. Naegeli & Stephanie de Bono

  3. Eli Lilly Services India Private Limited, Bangalore, India

    Pixy Banerjee

  4. Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Windmill Road Headington, Oxford, UK

    Peter C. Taylor

Authors
  1. Clifton O. Bingham III
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carol L. Gaich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amy M. DeLozier
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kathryn D. Engstrom
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. April N. Naegeli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stephanie de Bono
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Pixy Banerjee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Peter C. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Clifton O. Bingham III.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bingham, C.O., Gaich, C.L., DeLozier, A.M. et al. Correction to: Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation. Trials 20, 322 (2019). https://doi.org/10.1186/s13063-019-3463-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13063-019-3463-8

Trials

ISSN: 1745-6215